SEC Form 4 · accession 0001203311-15-000052
SEATTLE GENETICS INC /WA · SGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Clay B Siegall
Officer — President and CEO · Director
Period of report
Aug 20, 2015
Accepted (ET)
Aug 25, 2015 · 9:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001060736
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 20, 2015 | S | 31,754 | $42.0243 | D | 525,268 | D | |
| Common StockF2,F3,F4 | Aug 25, 2015 | A | 64,000 | $0.00 | A | 611,323 | D | |
| Common Stock | holding | — | — | — | 27,945 | I | by Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy)F5 | $39.15 | Aug 25, 2015 | A | 2,554 | A | — | Aug 25, 2025 | Common Stock | 2,554 | 2,554 | D |
| Non-Qualified Stock Option (right to buy)F5 | $39.15 | Aug 25, 2015 | A | 157,446 | A | — | Aug 25, 2025 | Common Stock | 157,446 | 157,446 | D |
Explanation of responses
- F1Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
- F2These shares represent restricted stock units and will be settled in common stock upon vesting.
- F3Restricted stock units shall vest in full three (3) years from grant date.
- F4Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. 22,055 shares previously held indirectly are now directly owned by reporting person pursuant to a grantor retained annuity trust distribution.
- F5Shares shall vest at a rate of 25% one year from grant date and monthly thereafter until all shares are fully vested four years from grant date.